NCT00206284 A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients Without Erosive Esophagitis. Status COMPLETED Phase PHASE2
NCT00206245 A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients With Erosive Esophagitis. Status COMPLETED Phase PHASE2
NCT00206219 Head and Neck Phase III Iressa Versus Methotrexate Refractory: Iressa Versus Methotrexate (IMEX) Status COMPLETED Phase PHASE3
NCT00206180 NEXIUM® in the Treatment of Moderate and Severe Erosive Esophagitis Status COMPLETED Phase PHASE4
NCT00206167 A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and 2 x 80/4.5 μg Bid With Formoterol Turbuhaler® 2 x 4.5 μg Bid and Placebo in Patients With COPD Status COMPLETED Phase PHASE3
NCT00206154 A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and Symbicort® pMDI 2 x 80/4.5 μg Bid With Formoterol Turbuhaler®, Budesonide pMDI, the Combination of Formoterol Turbuhaler® and Budesonide pMDI, and Placebo in COPD Patients Status COMPLETED Phase PHASE3
NCT00206128 Immediate Release (IR) to Sustained Release (SR) Switching Study: Study of Switching From IR Seroquel to SR Seroquel in Outpatients With Schizophrenia Status COMPLETED Phase PHASE3
NCT00206115 SR-Registration Study 1, ROW: Efficacy and Safety of Seroquel® in the Treatment of Patients With Schizophrenia Status COMPLETED Phase PHASE3
NCT00206102 A Study of the Cataractogenic Potential of Seroquel and Risperdal in the Treatment of Participants With Schizophrenia or Schizoaffective Disorder Status COMPLETED Phase PHASE4
NCT00206089 Melagatran/Ximelagatran Versus Enoxaparin for the Prevention of Venous Thromboembolic Events Status TERMINATED Phase PHASE3
NCT00206050 Study of Intragastric pH Profile After 5 Days Pantoprazole 40 mg iv Followed by Oral Esomeprazole 40 mg po or Oral Pantoprazole 40 mg po Status COMPLETED Phase PHASE4
NCT00206024 Acid-Associated Heartburn Symptoms and Dose of Esomeprazole Status COMPLETED Phase PHASE4
NCT00198393 Randomized Phase 2 Study of 3 Therapeutic Modalities in PS 2/3 Patients With NSCLC Stage IIIB/IV Status COMPLETED Phase PHASE2
NCT00198380 Treatment of Lung Adenocarcinoma With Bronchioloalveolar Feature Status COMPLETED Phase PHASE2
NCT00198159 A Phase II Study of Iressa in Patients With Chemo Refractory Germ Cell Tumors Expressing EGFR Status TERMINATED Phase PHASE2
NCT00193596 Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site Status COMPLETED Phase PHASE3